Industry perspectives for neurotranslation, Medtronic

Dr. Stephen Oesterle (Senior Vice President, Medicine and Technology, Medtronic, USA) seeks to translate neurotechnologies into practical applications. According to Dr. Oesterle, many physiological reactions can be reduced to electrochemical stimulation and so the field of ‘electroceuticals’ - encompassing all bioelectric medicine - has a plethora of potential applications.

About speaker:
Dr. Stephen Oesterle, M.D., joined Medtronic in 2002 as Senior Vice President for Medicine and Technology. In this role, Steve provides executive leadership for Medtronic scientific research, formation of technological strategies and continued development of strong cooperative relationships with the world's medical communities, technical universities, financial institutions and emerging medical device companies.

Previously, Dr. Oesterle served as Associate Professor of Medicine at the Harvard University Medical School and as Director of Invasive Cardiology Services at Massachusetts General Hospital, Boston. A teacher and innovator in the field of cardiac catheterization, he has also developed and directed interventional cardiology programs at Georgetown University and at Stanford University.

Dr. Oesterle participates as a director or observer for multiple device start-up companies and has served as an advisor to engineering boards at MIT, Stanford and University of Minnesota. He is a member of the Lemelson-MIT Prize jury. He is the chair of the executive advisory board for USA FIRST robotics in Minnesota.

Dr. Oesterle is a 1973 summa cum laude graduate of Harvard College and received his medical doctorate from Yale University in 1977. He completed his internship and residency at Massachusetts General Hospital and served a fellowship in interventional cardiology at Stanford.